{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:46:03Z","timestamp":1791827163931,"version":"4.3.4"},"reference-count":298,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jhep.2016.07.035","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T01:04:13Z","timestamp":1473987853000},"page":"S2-S21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":227,"special_numbering":"S","title":["The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control"],"prefix":"10.1016","volume":"65","author":[{"given":"Jens","family":"Bukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.07.035_b0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM197504102921502","article-title":"Transfusion-associated hepatitis not due to viral hepatitis type A or B","volume":"292","author":"Feinstone","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2009.08.004","article-title":"The long and winding road leading to the identification of the hepatitis C virus","volume":"51","author":"Houghton","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0015","first-page":"439","article-title":"Natural history and experimental models of hepatitis C. Viral Hepatitis","author":"Farci","year":"2005"},{"key":"10.1016\/j.jhep.2016.07.035_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","article-title":"Discovery of the hepatitis C virus","volume":"29","author":"Houghton","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.07.035_b0030","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM198911303212202","article-title":"Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis","volume":"321","author":"Alter","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0035","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1073\/pnas.90.5.1848","article-title":"Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma","volume":"90","author":"Bukh","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0040","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0140-6736(90)90474-J","article-title":"Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma","volume":"335","author":"Kew","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.07.035_b0045","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(89)91016-7","article-title":"Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma","volume":"2","author":"Colombo","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.07.035_b0050","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0055","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13027","article-title":"Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives","volume":"36","author":"Asselah","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.07.035_b0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000050040","article-title":"Studies of hepatitis C virus in chimpanzees and their importance for vaccine development","volume":"44","author":"Bukh","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.jhep.2016.07.035_b0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0168-8278(02)00308-2","article-title":"The challenge of developing a vaccine against hepatitis C virus","volume":"37","author":"Forns","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0085","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2016.07.035_b0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11908-007-0003-6","article-title":"Current status of a hepatitis C vaccine: encouraging results but significant challenges ahead","volume":"9","author":"Mikkelsen","year":"2007","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jhep.2016.07.035_b0100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0105","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/cis362","article-title":"Prospects for prophylactic and therapeutic vaccines against hepatitis C virus","volume":"55","author":"Feinstone","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b0110","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2010.09.040","article-title":"Progress in the development of preventive and therapeutic vaccines for hepatitis C virus","volume":"54","author":"Torresi","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","article-title":"Hepatitis C","volume":"385","author":"Webster","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.07.035_b0120","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0125","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1111\/liv.12931","article-title":"Ombitasvir\/paritaprevir\/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia","volume":"35","author":"Forns","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.07.035_b0130","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","article-title":"Genetic organization and diversity of the hepatitis C virus","volume":"88","author":"Choo","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0135","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1128\/JVI.70.6.3363-3371.1996","article-title":"Identification of a highly conserved sequence element at the 3\u2032 terminus of hepatitis C virus genome RNA","volume":"70","author":"Kolykhalov","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0140","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1006\/bbrc.1995.2526","article-title":"A novel sequence found at the 3\u2032 terminus of hepatitis C virus genome","volume":"215","author":"Tanaka","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2016.07.035_b0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-3527(08)00002-X","article-title":"Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems","volume":"71","author":"Gottwein","year":"2008","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.jhep.2016.07.035_b0150","series-title":"Ninth report of the international committee on taxonomy of viruses","first-page":"1003","article-title":"FLAVIVIRIDAE., Virus taxonomy: classification and nomenclature of viruses","author":"Simmonds","year":"2011"},{"key":"10.1016\/j.jhep.2016.07.035_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae","volume":"92","author":"Stapleton","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0160","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep.26770","article-title":"Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver","volume":"59","author":"Wieland","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0165","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pmbts.2014.10.003","article-title":"The mechanism of HCV entry into host cells","volume":"129","author":"Douam","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jhep.2016.07.035_b0175","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1128\/JVI.01150-06","article-title":"Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles","volume":"80","author":"Gastaminza","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0180","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.M115.662999","article-title":"Functional and biochemical characterization of hepatitis C virus (HCV) particles produced in a humanized liver mouse model","volume":"290","author":"Calattini","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b0185","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal models for the study of hepatitis C virus infection and related liver disease","volume":"142","author":"Bukh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0190","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0195","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"Dorner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/viro.1999.9941","article-title":"Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent","volume":"262","author":"Bukh","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.07.035_b0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2014.12.014","article-title":"Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses","volume":"115","author":"Scheel","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.07.035_b0220","doi-asserted-by":"crossref","first-page":"12563","DOI":"10.1073\/pnas.1107612108","article-title":"Hepatitis C homolog in dogs with respiratory illness","volume":"108","author":"Bukh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0225","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1101794108","article-title":"Characterization of a canine homolog of hepatitis C virus","volume":"108","author":"Kapoor","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0230","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1073\/pnas.1500265112","article-title":"Characterization of nonprimate hepacivirus and construction of a functional molecular clone","volume":"112","author":"Scheel","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0235","doi-asserted-by":"crossref","first-page":"8234","DOI":"10.1073\/pnas.90.17.8234","article-title":"At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide","volume":"90","author":"Bukh","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2007-1007262","article-title":"Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes","volume":"15","author":"Bukh","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b0245","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","article-title":"Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region","volume":"74","author":"Simmonds","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0250","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1086\/515683","article-title":"Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool","volume":"178","author":"Bukh","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b0255","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s007050050479","article-title":"Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy","volume":"143","author":"Robertson","year":"1998","journal-title":"Arch Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0260","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/bbrc.1997.6902","article-title":"The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa","volume":"236","author":"Chamberlain","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2016.07.035_b0270","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"Hepatitis C virus genotype 7, a new genotype originating from central Africa","volume":"53","author":"Murphy","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2016.07.035_b0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0280","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/vir.0.065128-0","article-title":"Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e","volume":"95","author":"Li","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.virol.2015.03.038","article-title":"The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages","volume":"482","author":"Lu","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.07.035_b0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.virol.2016.01.028","article-title":"Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype","volume":"492","author":"Lu","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.07.035_b0295","first-page":"1","article-title":"The origin of hepatitis C virus","volume":"369","author":"Simmonds","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2016.07.035_b0300","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tim.2014.02.005","article-title":"Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus","volume":"22","author":"Galli","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jhep.2016.07.035_b0305","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/JVI.76.8.4034-4043.2002","article-title":"A natural intergenotypic recombinant of hepatitis C virus identified in St","volume":"76","author":"Kalinina","year":"2002","journal-title":"Petersburg. J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0310","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.3748\/wjg.v12.i42.6756","article-title":"Mechanisms and significance of liver steatosis in hepatitis C virus infection","volume":"12","author":"Negro","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.07.035_b0315","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/hep.26905","article-title":"Is genotype 3 of the hepatitis C virus the new villain?","volume":"59","author":"Goossens","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0325","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0330","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/JCM.41.3.1091-1100.2003","article-title":"Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients","volume":"41","author":"Corbet","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2016.07.035_b0335","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1073\/pnas.91.17.8239","article-title":"Sequence analysis of the core gene of 14 hepatitis C virus genotypes","volume":"91","author":"Bukh","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0340","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/molbev\/msg043","article-title":"The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach","volume":"20","author":"Pybus","year":"2003","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jhep.2016.07.035_b0345","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/315786","article-title":"Genetic epidemiology of hepatitis C virus throughout Egypt","volume":"182","author":"Ray","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b0350","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1099\/0022-1317-75-4-931","article-title":"Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group","volume":"75","author":"Tokita","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0355","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.89.11.4942","article-title":"Sequence analysis of the 5\u2032 noncoding region of hepatitis C virus","volume":"89","author":"Bukh","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0360","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1073\/pnas.91.23.11022","article-title":"Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups","volume":"91","author":"Tokita","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00945022","article-title":"The quasispecies of hepatitis C virus and the host immune response","volume":"19","author":"Farci","year":"1997","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.jhep.2016.07.035_b0370","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(99)01590-5","article-title":"Quasispecies in viral persistence and pathogenesis of hepatitis C virus","volume":"7","author":"Forns","year":"1999","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jhep.2016.07.035_b0375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.07.035_b0380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.antiviral.2014.11.009","article-title":"T cell responses in hepatitis C virus infection: historical overview and goals for future research","volume":"114","author":"Holz","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.07.035_b0385","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0390","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.1600-6143.2009.02666.x","article-title":"Hepatitis C virus compartmentalization and infection recurrence after liver transplantation","volume":"9","author":"Ramirez","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2016.07.035_b0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2012.04.006","article-title":"Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies","volume":"143","author":"Fofana","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0400","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1099\/jgv.0.000289","article-title":"Quasispecies dynamics in hepatitis C liver transplant recipients receiving grafts from hepatitis C virus infected donors","volume":"96","author":"Perez-del-Pulgar","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0405","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.23192","article-title":"Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients","volume":"50","author":"Susser","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0410","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/jm401401n","article-title":"On the history of hepatitis C virus cell culture systems","volume":"57","author":"Lohmann","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b0415","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA","volume":"277","author":"Kolykhalov","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0420","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","article-title":"Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee","volume":"94","author":"Yanagi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0425","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","article-title":"Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies","volume":"84","author":"Gottwein","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0430","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/viro.1998.9092","article-title":"Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo","volume":"244","author":"Yanagi","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.07.035_b0435","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/viro.1999.9889","article-title":"Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras","volume":"262","author":"Yanagi","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.07.035_b0440","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/651579","article-title":"Challenge pools of hepatitis C virus genotypes 1\u20136 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models","volume":"201","author":"Bukh","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b0445","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.20268","article-title":"A critical role for the chimpanzee model in the study of hepatitis C","volume":"39","author":"Bukh","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0450","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.02654-10","article-title":"Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8 T cells in early viral evolution","volume":"85","author":"Callendret","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0455","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/JVI.73.4.3317-3325.1999","article-title":"Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus","volume":"73","author":"Major","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0460","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0465","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","article-title":"Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2032 nontranslated region are essential for virus replication in vivo","volume":"74","author":"Kolykhalov","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0470","doi-asserted-by":"crossref","first-page":"11646","DOI":"10.1073\/pnas.1834545100","article-title":"The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences","volume":"100","author":"Sakai","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0475","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.96.5.2291","article-title":"In vivo analysis of the 3\u2032 untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone","volume":"96","author":"Yanagi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0480","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1128\/JVI.01774-06","article-title":"In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells","volume":"81","author":"Sakai","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0485","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.mib.2006.06.012","article-title":"Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture","volume":"9","author":"Bartenschlager","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jhep.2016.07.035_b0490","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2007.02.022","article-title":"Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture","volume":"127","author":"Bartenschlager","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.jhep.2016.07.035_b0495","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0500","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0505","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0510","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/JVI.75.3.1437-1449.2001","article-title":"Mutations in hepatitis C virus RNAs conferring cell culture adaptation","volume":"75","author":"Lohmann","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0515","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/JVI.77.5.3007-3019.2003","article-title":"Viral and cellular determinants of hepatitis C virus RNA replication in cell culture","volume":"77","author":"Lohmann","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0520","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-59745-394-3_11","article-title":"HCV replicons: overview and basic protocols","volume":"510","author":"Lohmann","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2016.07.035_b0525","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2005.05.013","article-title":"The hepatitis C virus replicon system: from basic research to clinical application","volume":"43","author":"Bartenschlager","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0530","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/JVI.77.5.3181-3190.2003","article-title":"Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture","volume":"77","author":"Blight","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0535","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1074\/jbc.M212602200","article-title":"Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase","volume":"278","author":"Grobler","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b0540","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1128\/JVI.76.6.2997-3006.2002","article-title":"Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells","volume":"76","author":"Ikeda","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0545","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1128\/JVI.78.15.7904-7915.2004","article-title":"Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells","volume":"78","author":"Yi","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0550","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1128\/AAC.01256-12","article-title":"Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells","volume":"56","author":"Saeed","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0555","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.gastro.2012.09.017","article-title":"Replication of hepatitis C virus genotype 3a in cultured cells","volume":"144","author":"Saeed","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0560","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","article-title":"Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon","volume":"125","author":"Kato","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0565","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2012.09.033","article-title":"Development of robust hepatitis C virus genotype 4 subgenomic replicons","volume":"144","author":"Peng","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0570","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1128\/AAC.03534-14","article-title":"Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents","volume":"58","author":"Wose Kinge","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0575","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/AAC.01780-13","article-title":"Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture","volume":"58","author":"Yu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0580","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jmv.1055","article-title":"Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient","volume":"64","author":"Kato","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0585","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature14899","article-title":"SEC14L2 enables pan-genotype HCV replication in cell culture","volume":"524","author":"Saeed","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0590","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/AAC.02932-15","article-title":"Enhancement of the replication of hepatitis C virus replicons of genotypes 1 to 4 by manipulation of CpG and UpA dinucleotide frequencies and use of cell lines expressing SECL14L2 for antiviral resistance testing","volume":"60","author":"Witteveldt","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0595","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.212532699","article-title":"Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees","volume":"99","author":"Bukh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000475","article-title":"Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations","volume":"5","author":"Pietschmann","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b0605","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1128\/JVI.07235-11","article-title":"Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone","volume":"86","author":"Date","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0610","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/hep.27197","article-title":"Development of hepatitis C virus genotype 3a cell culture system","volume":"60","author":"Kim","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0615","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1073\/pnas.0510727103","article-title":"Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells","volume":"103","author":"Yi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0620","first-page":"167","article-title":"Hepatitis C virus RNA replication","volume":"369","author":"Lohmann","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2016.07.035_b0625","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhep.2016.07.035_b0630","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0635","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0640","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0645","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0650","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.0711044105","article-title":"Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization","volume":"105","author":"Scheel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0655","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1073\/pnas.0800422105","article-title":"Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus","volume":"105","author":"Russell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0660","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1128\/JVI.01362-07","article-title":"Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant","volume":"81","author":"Kaul","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0665","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hep.22422","article-title":"Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation","volume":"48","author":"Kato","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0670","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.0511218103","article-title":"Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro","volume":"103","author":"Lindenbach","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0675","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1073\/pnas.0600551103","article-title":"A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo","volume":"103","author":"Bukh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0680","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0685","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2011.06.004","article-title":"Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3\/4A protease recombinant viruses","volume":"141","author":"Gottwein","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0690","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1128\/AAC.01176-13","article-title":"Adapted J6\/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor","volume":"57","author":"Gottwein","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0695","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/AAC.02164-12","article-title":"Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses","volume":"57","author":"Gottwein","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0700","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/593021","article-title":"Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: Failure of Homologous Neutralizing-Antibody Treatment to Control Infection","volume":"198","author":"Jensen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b0705","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1073\/pnas.1016606108","article-title":"MicroRNA-122 antagonism against hepatitis C virus genotypes 1\u20136 and reduced efficacy by host RNA insertion or mutations in the HCV 5\u2032 UTR","volume":"108","author":"Li","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0710","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2013.11.009","article-title":"Differential sensitivity of 5\u2032UTR-NS5A recombinants of hepatitis C virus genotypes 1\u20136 to protease and NS5A inhibitors","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0715","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/hep.26524","article-title":"Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies","volume":"58","author":"Pedersen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0720","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0725","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/JVI.01605-10","article-title":"Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations","volume":"85","author":"Scheel","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0730","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.gastro.2010.11.036","article-title":"Recombinant HCV variants with NS5A from genotypes 1\u20137 have different sensitivities to an NS5A inhibitor but not interferon-alpha","volume":"140","author":"Scheel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b0735","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/JVI.01890-06","article-title":"Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus","volume":"81","author":"Yi","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0740","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1099\/vir.0.053868-0","article-title":"Analysis of hepatitis C virus core\/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1\u20137","volume":"94","author":"Galli","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0745","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1128\/JVI.05386-11","article-title":"Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1","volume":"86","author":"Murayama","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0750","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/JVI.00039-15","article-title":"Adaptive mutations enhance assembly and cell-to-cell transmission of a high-titer hepatitis C virus genotype 5a Core-NS2 JFH1-based recombinant","volume":"89","author":"Mathiesen","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0755","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0760","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/JVI.01941-12","article-title":"Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein","volume":"87","author":"Keck","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002653","article-title":"Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate","volume":"8","author":"Keck","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b0770","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1073\/pnas.1203829109","article-title":"Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0775","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1073\/pnas.1218260109","article-title":"Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0780","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.26660","article-title":"Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors","volume":"59","author":"Ramirez","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0785","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JVI.02877-14","article-title":"Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77","volume":"89","author":"Li","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0790","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/JVI.02052-13","article-title":"Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain","volume":"88","author":"Kohlway","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0795","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm.3610","article-title":"Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation","volume":"20","author":"Yamane","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0800","doi-asserted-by":"crossref","unstructured":"Ramirez S, Mikkelsen LS, Gottwein JM, Bukh J. Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir. Gastroenterology. In press. http:\/\/dx.doi.org\/10.1053\/j.gastro.2016.07.013.","DOI":"10.1053\/j.gastro.2016.07.013"},{"key":"10.1016\/j.jhep.2016.07.035_b0805","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.3248","article-title":"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies","volume":"19","author":"Scheel","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0810","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1073\/pnas.0915130107","article-title":"Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures","volume":"107","author":"Ploss","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0815","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2012.03.030","article-title":"Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus","volume":"57","author":"Roelandt","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070809","article-title":"Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus","volume":"8","author":"Helle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.035_b0825","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2011.11.007","article-title":"Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection","volume":"416","author":"Yoshida","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2016.07.035_b0830","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00273-16","article-title":"Completion of the entire hepatitis C virus life cycle in vero cells derived from monkey kidney","volume":"7","author":"Murayama","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.jhep.2016.07.035_b0835","doi-asserted-by":"crossref","first-page":"13215","DOI":"10.1073\/pnas.0705890104","article-title":"Hepatitis C virus host cell interactions uncovered","volume":"104","author":"Gottwein","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0840","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1073\/pnas.0704894104","article-title":"Cellular cofactors affecting hepatitis C virus infection and replication","volume":"104","author":"Randall","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0845","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/JVI.73.2.1165-1174.1999","article-title":"A phylogenetically conserved stem-loop structure at the 5\u2032 border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation","volume":"73","author":"Honda","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0850","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1038\/emboj.2008.244","article-title":"MicroRNA-122 stimulates translation of hepatitis C virus RNA","volume":"27","author":"Henke","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2016.07.035_b0855","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1042\/BST0361220","article-title":"Regulation of hepatitis C virus by microRNA-122","volume":"36","author":"Jopling","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jhep.2016.07.035_b0860","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1073\/pnas.1012464108","article-title":"Masking the 5\u2032 terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex","volume":"108","author":"Machlin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0865","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1093\/nar\/gkr426","article-title":"MiR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components","volume":"39","author":"Roberts","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2016.07.035_b0870","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.chom.2014.12.014","article-title":"MiR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation","volume":"17","author":"Masaki","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2016.07.035_b0875","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0880","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1073\/pnas.1213515110","article-title":"Competing and noncompeting activities of miR-122 and the 5\u2032 exonuclease Xrn1 in regulation of hepatitis C virus replication","volume":"110","author":"Li","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0885","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2015.02.025","article-title":"Hepatitis C virus RNA functionally sequesters miR-122","volume":"160","author":"Luna","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2016.07.035_b0890","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Elmen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0895","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0900","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0905","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/AAC.04220-14","article-title":"In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122","volume":"59","author":"Ottosen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b0910","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1099\/jgv.0.000445","article-title":"Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir","volume":"97","author":"Li","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0915","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/ncomms6408","article-title":"Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors","volume":"5","author":"Israelow","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.07.035_b0920","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b0925","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0930","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b0935","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1128\/JVI.01573-06","article-title":"CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection","volume":"81","author":"Akazawa","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0940","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0945","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.virol.2014.03.021","article-title":"Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1\u20136","volume":"458\u2013459","author":"Mathiesen","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.07.035_b0950","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/JVI.02017-13","article-title":"Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus","volume":"88","author":"Prentoe","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b0955","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2016.07.035_b0960","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0965","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.24110","article-title":"Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics","volume":"53","author":"Mensa","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b0970","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b0975","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1","volume":"102","author":"Meunier","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b0980","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0985","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.07.035_b0990","doi-asserted-by":"crossref","first-page":"21808","DOI":"10.1038\/srep21808","article-title":"CD36 is a co-receptor for hepatitis C virus E1 protein attachment","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2016.07.035_b0995","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1073\/pnas.1301764110","article-title":"Identification of transferrin receptor 1 as a hepatitis C virus entry factor","volume":"110","author":"Martin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1000","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2012.02.018","article-title":"Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice","volume":"57","author":"Lacek","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b1005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"Meuleman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.24692","article-title":"A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo","volume":"55","author":"Meuleman","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/lt.24349","article-title":"Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation","volume":"22","author":"Rowe","year":"2016","journal-title":"Liver transpl"},{"key":"10.1016\/j.jhep.2016.07.035_b1020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/infdis\/jit503","article-title":"Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study","volume":"209","author":"Sulkowski","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b1025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt.3179","article-title":"Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody","volume":"33","author":"Mailly","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2016.07.035_b1030","doi-asserted-by":"crossref","unstructured":"Colpitts CC, Baumert TF. Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals. Hepatol Int. In press. http:\/\/dx.doi.org\/10.1007\/s12072-016-9724-7.","DOI":"10.1007\/s12072-016-9724-7"},{"key":"10.1016\/j.jhep.2016.07.035_b1035","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3390\/v4112558","article-title":"Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection","volume":"4","author":"Hopkins","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2016.07.035_b1040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: the example of cyclophilin inhibitors","volume":"99","author":"Lin","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.07.035_b1045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2016.07.035_b1050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins","volume":"129","author":"Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1055","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/AAC.00310-06","article-title":"NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon","volume":"50","author":"Ma","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b1060","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/29dffb2a-5d37-4196-b166-b0b15bc2f3fd","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b1065","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/hep.23587","article-title":"Multiple effects of silymarin on the hepatitis C virus lifecycle","volume":"51","author":"Wagoner","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1070","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.67.5.2832-2843.1993","article-title":"Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites","volume":"67","author":"Grakoui","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0092-8674(00)81351-3","article-title":"Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide","volume":"87","author":"Kim","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2016.07.035_b1080","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nature04975","article-title":"Structure of the catalytic domain of the hepatitis C virus NS2-3 protease","volume":"442","author":"Lorenz","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b1085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81350-1","article-title":"The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site","volume":"87","author":"Love","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2016.07.035_b1090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0928-0197(98)00036-1","article-title":"The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor","volume":"10","author":"Love","year":"1998","journal-title":"Clin Diagn Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1095","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1128\/JVI.02698-09","article-title":"Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6","volume":"84","author":"Imhof","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1100","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1128\/AAC.01953-15","article-title":"Substitutions at NS3 residue 155, 156, or 168 of hepatitis C virus genotypes 2 to 6 induce complex patterns of protease inhibitor resistance","volume":"59","author":"Jensen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b1105","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1128\/AAC.02929-15","article-title":"Hepatitis C virus genotype 1 to 6 protease inhibitor escape variants. In vitro selection, fitness, and resistance patterns in the context of the infectious viral life cycle","volume":"60","author":"Serre","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.07.035_b1110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region","volume":"96","author":"Enomoto","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.07.035_b1115","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1128\/JVI.77.9.5487-5492.2003","article-title":"Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons","volume":"77","author":"Gosert","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1120","doi-asserted-by":"crossref","first-page":"48576","DOI":"10.1074\/jbc.M407787200","article-title":"The NS5A protein of hepatitis C virus is a zinc metalloprotein","volume":"279","author":"Tellinghuisen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b1125","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1128\/JVI.77.10.6055-6061.2003","article-title":"Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication","volume":"77","author":"Elazar","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1130","doi-asserted-by":"crossref","first-page":"40835","DOI":"10.1074\/jbc.M404761200","article-title":"Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A","volume":"279","author":"Penin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b1135","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.02352-08","article-title":"Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus","volume":"83","author":"Love","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature03580","article-title":"Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase","volume":"435","author":"Tellinghuisen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b1145","doi-asserted-by":"crossref","first-page":"36417","DOI":"10.1074\/jbc.M508175200","article-title":"Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein","volume":"280","author":"Huang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.07.035_b1150","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/JVI.00328-07","article-title":"Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein","volume":"82","author":"Tellinghuisen","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1155","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/JVI.79.5.3187-3194.2005","article-title":"Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain","volume":"79","author":"Appel","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1160","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00759-15","article-title":"NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication","volume":"6","author":"Romero-Brey","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.jhep.2016.07.035_b1165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000035","article-title":"Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly","volume":"4","author":"Appel","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b1170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002696","article-title":"Analysis of functional differences between hepatitis C virus NS5A of genotypes 1\u20137 in infectious cell culture systems","volume":"8","author":"Scheel","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b1175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005376","article-title":"Coordination of hepatitis C virus assembly by distinct regulatory regions in nonstructural protein 5A","volume":"12","author":"Zayas","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b1180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.035_b1185","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1053\/j.gastro.2014.07.019","article-title":"Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication","volume":"147","author":"Berger","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1190","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1128\/JVI.77.13.7575-7581.2003","article-title":"Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme","volume":"77","author":"Love","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1195","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jhep.2016.07.035_b1200","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","article-title":"Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"96","author":"Bressanelli","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1205","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0969-2126(00)80031-3","article-title":"Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"7","author":"Ago","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.jhep.2016.07.035_b1210","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.035_b1215","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.035_b1220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1279801","article-title":"Lack of protective immunity against reinfection with hepatitis C virus","volume":"258","author":"Farci","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b1225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/infdis\/165.3.438","article-title":"Immunity in hepatitis C infection","volume":"165","author":"Prince","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b1230","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","article-title":"Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection","volume":"33","author":"Bassett","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1235","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/496889","article-title":"Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model","volume":"192","author":"Prince","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b1240","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1245","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1128\/JVI.00142-08","article-title":"Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain","volume":"82","author":"Bukh","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1250","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes","volume":"100","author":"Bartosch","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1255","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1260","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1128\/JVI.01332-10","article-title":"Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype","volume":"85","author":"Tarr","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1265","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1270","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1275","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1280","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1128\/JVI.00459-07","article-title":"Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization","volume":"81","author":"Falkowska","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1285","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"Helle","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1290","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jmb.2013.02.025","article-title":"Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies","volume":"425","author":"Pantua","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jhep.2016.07.035_b1295","doi-asserted-by":"crossref","unstructured":"Prentoe J, Velazquez-Moctezuma R, Foung SK, Law M, Bukh J. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity. Hepatology. In press. http:\/\/dx.doi.org\/10.1002\/hep.28705.","DOI":"10.1002\/hep.28705"},{"key":"10.1016\/j.jhep.2016.07.035_b1300","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1305","doi-asserted-by":"crossref","first-page":"19450","DOI":"10.1073\/pnas.0809879105","article-title":"In vitro selection of a neutralization-resistant hepatitis C virus escape mutant","volume":"105","author":"Gal-Tanamy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.035_b1315","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b1320","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1128\/JVI.01911-14","article-title":"Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization","volume":"88","author":"Wong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1325","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/655902","article-title":"Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins","volume":"202","author":"Ray","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b1330","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus","volume":"53","author":"Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1335","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1340","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1128\/JVI.01194-15","article-title":"Immunoglobulin with high-titer in vitro cross-neutralizing hepatitis C virus antibodies passively protects chimpanzees from homologous, but not heterologous, challenge","volume":"89","author":"Bukh","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1345","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/infdis\/173.4.822","article-title":"Effect of immune globulin on the prevention of experimental hepatitis C virus infection","volume":"173","author":"Krawczynski","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.035_b1350","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"Farci","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1355","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b1360","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1365","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2010.05.077","article-title":"Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins","volume":"139","author":"Dahari","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1370","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jhep.2016.07.035_b1375","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/jhep.2000.9877","article-title":"Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV","volume":"32","author":"Forns","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1380","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2013.05.007","article-title":"Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice","volume":"145","author":"Akazawa","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1390","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2013.136","article-title":"Viral hepatitis: Cell-culture-derived HCV\u2013a promising vaccine antigen","volume":"10","author":"Gottwein","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.07.035_b1395","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.0902749106","article-title":"Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1400","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.27298","article-title":"Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a","volume":"60","author":"Carlsen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.07.035_b1410","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/ajt.12083","article-title":"Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study","volume":"13","author":"Chung","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2016.07.035_b1415","doi-asserted-by":"crossref","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2016.07.035_b1420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.035_b1425","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.gastro.2015.09.014","article-title":"Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies","volume":"150","author":"Fauvelle","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.035_b1430","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1128\/JVI.01548-10","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions","volume":"84","author":"Helle","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1435","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1440","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"Prentoe","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1445","doi-asserted-by":"crossref","unstructured":"Prentoe J, Verhoye L, Velazquez MR, Buysschaert C, Farhoudi A, Wang R, et al. HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice. Gut. In press. http:\/\/dx.doi.org\/10.1136\/gutjnl-2015-310300.","DOI":"10.1136\/gutjnl-2015-310300"},{"key":"10.1016\/j.jhep.2016.07.035_b1450","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.230453597","article-title":"Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees","volume":"97","author":"Forns","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.035_b1455","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross-genotype immunity to hepatitis C virus","volume":"78","author":"Lanford","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.035_b1460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-385032-4.00002-1","article-title":"Adaptive immunity to the hepatitis C virus","volume":"78","author":"Walker","year":"2010","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.jhep.2016.07.035_b1465","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.035_b1470","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.07.035_b1475","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coi.2015.06.010","article-title":"Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?","volume":"35","author":"Walker","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jhep.2016.07.035_b1480","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2016.07.035_b1485","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"186","author":"Mikkelsen","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.07.035_b1490","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816304056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816304056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:11:22Z","timestamp":1601071882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816304056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":298,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0168827816304056"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.07.035","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}